The unique delivery platform developed by ANANDA Scientific has successfully addressed a critical need for utilizing cannabinoids as medication, effectively facilitating their entry into the bloodstream. ANANDA Scientific is leveraging this platform in conjunction with CBD to target important therapeutic goals for public health in North America, China, and other regions. Additionally, the company is pursuing a distinct product development pathway to secure regulatory approval and endorsement by healthcare professionals, including conducting human clinical trials where research on cannabinoids is limited.